|
|
| |
|
Product #
|
Description
|
Molecular Formula
|
|
Add to Cart
|
|
H6910
|
13S-Hydroxy-9Z,11E-octadecadiene-(2-biotinyl)hydrazide ≥98%, ethanol solution
|
C28H28N4O4S
|
516.6
|
|
|
|
|
H6785
|
15(S)-Hydroxy-(5Z,8Z,11Z,13E)-eicosatetraene-(2-biotinyl)hydrazide ≥98%, ethanol solution
|
C30H48N4O4S
|
560.8
|
|
|
|
|
D8440
|
15-Deoxy-Δ12,14-prostaglandin J2 ≥95% (HPLC), methyl acetate solution
|
C20H28O3
|
316.4
|
|
|
|
|
D0160
|
16,16-Dimethylprostaglandin E2 methyl acetate solution
|
C22H36O5
|
380.5
|
|
|
|
|
P6615
|
17-Phenyl-tri-norprostaglandin D2 ≥98%, methyl acetate solution
|
C23H30O5
|
386.5
|
|
|
|
|
D8174
|
9,11-Dideoxy-11α,9α-epoxymethanoprostaglandin F2α solution, 10 mg/mL in methyl acetate
|
C21H34O4
|
350.5
|
|
|
|
|
D0400
|
9,11-Dideoxy-9α,11α-epoxymethanoprostaglandin F2α
|
C21H34O4
|
350.5
|
|
|
|
|
A0593
|
Alprostadil meets USP testing specifications
|
C20H34O5
|
354.5
|
|
|
|
|
C3305
|
Carbacyclin ≥90% (HPLC)
|
C21H34O4
|
350.5
|
|
|
|
|
62170
|
Linolenic acid ~70% (GC)
|
CH3(CH2CH=CH)3(CH2)7CO2H
|
278.4
|
|
|
|
|
M6932
|
Misoprostol free acid ≥90%
|
C21H36O5
|
368.5
|
|
|
|
|
M6807
|
Misoprostol ≥99% (TLC)
|
C22H38O5
|
382.5
|
|
|
|
|
P7265
|
Prostaglandin A1 synthetic
|
C20H32O4
|
336.5
|
|
|
|
|
82467
|
Prostaglandin B1 ≥99.0% (TLC)
|
C20H32O4
|
336.5
|
|
|
|
|
P5265
|
Prostaglandin B1 synthetic, powder
|
C20H32O4
|
336.5
|
|
|
|
|
P5390
|
Prostaglandin B2 ≥98%, synthetic
|
C20H30O4
|
334.5
|
|
|
|
|
P5172
|
Prostaglandin D2 ≥95%, synthetic
|
C20H32O5
|
352.5
|
|
|
|
|
P5515
|
Prostaglandin E1 ≥98% (HPLC), synthetic
|
C20H34O5
|
354.5
|
|
|
|
|
P7527
|
Prostaglandin E1 powder, γ-irradiated, BioXtra, suitable for cell culture
|
C20H34O5
|
354.5
|
|
|
|
|
P8908
|
Prostaglandin E1 synthetic, powder, BioReagent, suitable for cell culture
|
C20H34O5
|
354.5
|
|
|
|
|
P5640
|
Prostaglandin E2 ≥93% (HPLC), synthetic
|
C20H32O5
|
352.5
|
|
|
|
|
82475
|
Prostaglandin E2 ≥99.0% (TLC)
|
C20H32O5
|
352.5
|
|
|
|
|
P6532
|
Prostaglandin E2 γ-irradiated, powder, BioXtra, suitable for cell culture
|
C20H32O5
|
352.5
|
|
|
|
|
P0409
|
Prostaglandin E2 synthetic, powder, BioReagent, suitable for cell culture
|
C20H32O5
|
352.5
|
|
|
|
|
82476
|
Prostaglandin F1α ≥99.0% (TLC)
|
C20H36O5
|
356.5
|
|
|
|
|
P5765
|
Prostaglandin F1α synthetic
|
C20H36O5
|
356.5
|
|
|
|
|
P6738
|
Prostaglandin F2α ethanolamide ≥98%
|
C22H39NO5
|
397.6
|
|
|
|
|
P0314
|
Prostaglandin F2α methyl ester ~5 mg/mL in methyl acetate, ≥95% (HPLC)
|
C21H36O5
|
368.5
|
|
|
|
|
P0424
|
Prostaglandin F2α tris salt ≥99%, synthetic, powder
|
C20H34O5 · C4H11NO3
|
475.6
|
|
|
|
|
P5069
|
Prostaglandin F2α tris salt synthetic, cell culture tested
|
C20H34O5 · C4H11NO3
|
475.6
|
|
|
|
|
P7617
|
Prostaglandin G1 >95% (HPLC), acetone solution
|
C20H34O6
|
370.5
|
|
|
|
|
P7742
|
Prostaglandin G2 ≥95% (HPLC), acetone solution
|
C20H32O6
|
368.5
|
|
|
|
|
P7867
|
Prostaglandin H2 ≥95% (HPLC), acetone solution
|
C20H32O5
|
352.5
|
|
|
|
|
P6188
|
Prostaglandin I2 sodium salt ≥96% (HPLC), synthetic, powder
|
C20H31NaO5
|
374.5
|
|
|
|
|
S8692
|
Sulprostone ≥95% (HPLC), oil
|
C23H31NO7S
|
465.6
|
|
|
|
|
T4949
|
Taprostene sodium salt ≥98% (HPLC)
|
C24H29NaO5
|
420.5
|
|
|
|
|
T0516
|
Thromboxane B2
|
C20H34O6
|
370.5
|
|
|
|
|
|